HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AG 2034

inhibits glycinamide ribonucleotide formyltransferase; structure given in first source
Also Known As:
4-(2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino(5,4-6)(1,4)thiazin-6-yl)-(S)-ethyl)-2,5-thienoyl-L-glutamic acid; AG2034
Networked: 5 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Fang, Hong-Bin: 1 article (01/2010)
2. Tan, Ming: 1 article (01/2010)
3. Yu, Tinghui: 1 article (01/2010)
4. Obajimi, Oluwakemi: 1 article (07/2008)
5. Melera, Peter W: 1 article (07/2008)
6. Collier, M: 1 article (02/2001)
7. Sheedy, B: 1 article (02/2001)
8. Paradiso, L: 1 article (02/2001)
9. Bissett, D: 1 article (02/2001)
10. Cassidy, J: 1 article (02/2001)

Related Diseases

1. Neoplasms (Cancer)
2. Prostatic Neoplasms (Prostate Cancer)
3. Carcinoma (Carcinomatosis)
4. Adenocarcinoma

Related Drugs and Biologics

1. Folic Acid (Vitamin M)
2. glycinamide ribonucleotide
3. Trimetrexate (JB11)
4. Hypoxanthine
5. Paclitaxel (Taxol)
6. Methotrexate (Mexate)
7. Doxorubicin (Adriamycin)
8. Cisplatin (Platino)
9. Adenosine Triphosphate (ATP)
10. raltitrexed (D 1694)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)